Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
    2.
    发明授权
    Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture 有权
    胸腺抑素的药学上可接受的盐及其制造方法

    公开(公告)号:US08138221B2

    公开(公告)日:2012-03-20

    申请号:US12520337

    申请日:2007-12-13

    IPC分类号: A61K31/404 C07D209/12

    摘要: The present invention relates to pharmaceutically acceptable crystalline and amorphous salts of D-isoglutamyl-D-tryptophan as well as processes for their manufacture, pharmaceutical compositions comprising them, and their uses in the preparation of pharmaceutical compositions for the treatment of various conditions and/or diseases. In particular, the present invention relates to D-isoglutamyl-D-tryptophan potassium salt (1:1), D-isoglutamyl-D-tryptophan lithium salt (1:1), D-isoglutamyl-D-tryptophan calcium salt (2:1), D-isoglutamyl-D-tryptophan magnesium salt (2:1), and D-isoglutamyl-D-tryptophan organic ammonium salts (1:1).

    摘要翻译: 本发明涉及D-异谷氨酰-D-色氨酸的药学上可接受的结晶和无定形盐以及其制备方法,包含它们的药物组合物及其在制备药物组合物中用于治疗各种病症和/或 疾病 特别地,本发明涉及D-异谷氨酰-D-色氨酸钾盐(1:1),D-异谷氨酰基-D-色氨酸锂盐(1:1),D-异谷氨酰-D-色氨酸钙盐(2: 1),D-异谷氨酰-D-色氨酸镁盐(2:1)和D-异谷氨酰-D-色氨酸有机铵盐(1:1)。

    Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
    6.
    发明授权
    Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture 有权
    胸腺抑素的药学上可接受的盐及其制造方法

    公开(公告)号:US08735602B2

    公开(公告)日:2014-05-27

    申请号:US13424343

    申请日:2012-03-19

    IPC分类号: C07D209/12

    摘要: The present invention relates to pharmaceutically acceptable crystalline and amorphous salts of D-isoglutamyl-D-tryptophan as well as processes for their manufacture, pharmaceutical compositions comprising them, and their uses in the preparation of pharmaceutical compositions for the treatment of various conditions and/or diseases. In particular, the present invention relates to D-isoglutamyl-D-tryptophan potassium salt (1:1), D-isoglutamyl-D-tryptophan lithium salt (1:1), D-isoglutamyl-D-tryptophan calcium salt (2:1), D-isoglutamyl-D-tryptophan magnesium salt (2:1), and D-isoglutamyl-D-tryptophan organic ammonium salts (1:1).

    摘要翻译: 本发明涉及D-异谷氨酰-D-色氨酸的药学上可接受的结晶和无定形盐以及其制备方法,包含它们的药物组合物及其在制备药物组合物中用于治疗各种病症和/或 疾病 特别地,本发明涉及D-异谷氨酰-D-色氨酸钾盐(1:1),D-异谷氨酰基-D-色氨酸锂盐(1:1),D-异谷氨酰-D-色氨酸钙盐(2: 1),D-异谷氨酰-D-色氨酸镁盐(2:1)和D-异谷氨酰-D-色氨酸有机铵盐(1:1)。

    PHARMACEUTICALLY ACCEPTABLE SALTS OF THYMODEPRESSIN AND PREOCESSES FOR THEIR MANUFACTURE.
    9.
    发明申请
    PHARMACEUTICALLY ACCEPTABLE SALTS OF THYMODEPRESSIN AND PREOCESSES FOR THEIR MANUFACTURE. 有权
    药用药物的药用盐及其制造方法。

    公开(公告)号:US20130072692A1

    公开(公告)日:2013-03-21

    申请号:US13424343

    申请日:2012-03-19

    IPC分类号: C07D209/20

    摘要: The present invention relates to pharmaceutically acceptable crystalline and amorphous salts of D-isoglutamyl-D-tryptophan as well as processes for their manufacture, pharmaceutical compositions comprising them, and their uses in the preparation of pharmaceutical compositions for the treatment of various conditions and/or diseases. In particular, the present invention relates to D-isoglutamyl-D-tryptophan potassium salt (1:1), D-isoglutamyl-D-tryptophan lithium salt (1:1), D-isoglutamyl-D-tryptophan calcium salt (2:1), D-isoglutamyl-D-tryptophan magnesium salt (2:1), and D-isoglutamyl-D-tryptophan organic ammonium salts (1:1).

    摘要翻译: 本发明涉及D-异谷氨酰-D-色氨酸的药学上可接受的结晶和无定形盐以及其制备方法,包含它们的药物组合物及其在制备药物组合物中用于治疗各种病症和/或 疾病 特别地,本发明涉及D-异谷氨酰-D-色氨酸钾盐(1:1),D-异谷氨酰基-D-色氨酸锂盐(1:1),D-异谷氨酰-D-色氨酸钙盐(2: 1),D-异谷氨酰-D-色氨酸镁盐(2:1)和D-异谷氨酰-D-色氨酸有机铵盐(1:1)。